APA (7th ed.) Citation

Kollins, D., Papachristofi, O., Hach, T., Jacinto-Sanders, S., Merkel, T., Schmouder, R., . . . Perkovic, V. WCN25-797 SAFETY AND EFFICACY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN) WITH BASELINE eGFR 20-<30 mL/MIN: PHASE 3 APPLAUSE-IgAN SUBCOHORT RESULTS. Elsevier.

Chicago Style (17th ed.) Citation

Kollins, Dmitrij, Olympia Papachristofi, Thomas Hach, Severina Jacinto-Sanders, Tobias Merkel, Robert Schmouder, Kenneth Kulmatycki, Ronny Renfurm, and Vlado Perkovic. WCN25-797 SAFETY AND EFFICACY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN) WITH BASELINE EGFR 20-<30 ML/MIN: PHASE 3 APPLAUSE-IgAN SUBCOHORT RESULTS. Elsevier.

MLA (9th ed.) Citation

Kollins, Dmitrij, et al. WCN25-797 SAFETY AND EFFICACY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN) WITH BASELINE EGFR 20-<30 ML/MIN: PHASE 3 APPLAUSE-IgAN SUBCOHORT RESULTS. Elsevier.